Pharma is entering a transformative business environment that creates an unprecedented focus on organizational decision making and its ties to Return-On-Investment (ROI) and business productivity. This focus has special relevance for R&D functions where decisions are based on the constant expansion of scientific and medical knowledge ...

In today's business environment collaboration is becoming an essential component of successful drug discovery and development. Spurred by factors including the need to improve drug pipelines, external capabilities and cost structures, and the potential to open new markets through in-licensing and out-licensing, ...